Cheng Hu
Fortuna: 35 M $ al 31/05/2026
Fortuna: 35 M $ al 31/05/2026
Cheng Hu worked at Chengdu.
Olymvax.
Biopharmaceuticals, Inc. from 2013 to 2025, serving as Director & Deputy General Manager from 2022 to 2025.
Mr. Hu graduated from Southwest Jiaotong University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/03/2026 | 6.666.125 ( 1,64 % ) | 35 M $ | 31/05/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| CHENGDU OLYMVAX BIOPHARMACEUTICALS INC. | Presidente | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
Southwest Jiaotong University
Southwest Jiaotong University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chengdu Olymvax Biopharmaceuticals, Inc.
Chengdu Olymvax Biopharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a holding company whose subsidiaries engages in research and development, manufacturing & sale of vaccine products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.